LEADER 04414nam 22007335 450 001 9910253921503321 005 20200705103645.0 010 $a3-319-57535-X 024 7 $a10.1007/978-3-319-57535-3 035 $a(CKB)3710000001388812 035 $a(DE-He213)978-3-319-57535-3 035 $a(MiAaPQ)EBC4867938 035 $a(PPN)201472619 035 $a(EXLCZ)993710000001388812 100 $a20170530d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBehavioral Neuroscience of Orexin/Hypocretin /$fedited by Andrew J Lawrence, Luis de Lecea 205 $a1st ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017. 215 $a1 online resource (VIII, 322 p. 30 illus., 22 illus. in color.) 225 1 $aCurrent Topics in Behavioral Neurosciences,$x1866-3370 ;$v33 311 $a3-319-57534-1 320 $aIncludes bibliographical references at the end of each chapters. 327 $aThe Human Orexin/Hypocretin Receptor Crystal Structures -- Orexin/Hypocretin Signaling -- Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain -- The Hypocretin/Orexin Neuronal Networks in Zebrafish -- Hypocretins and Arousal -- Orexin OX 2 Receptor Antagonists as Sleep Aids -- Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism -- Orexin and Central Modulation of Cardiovascular and Respiratory Function -- Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders -- The Role of Orexins/Hypocretins in Alcohol Use and Abuse -- A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?- Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse. 330 $aThis issue of Current Topics in Behavioral Neuroscience focuses on the neuropeptide orexin (hypocretin) and brings together scientists from around the world who will provide a timely discussion of how this peptide regulates behavior. This is a fast-moving field, and with the incorporation of novel technologies, new breakthroughs are likely to continue. For example, the use of optogenetic approaches has enabled the identification of the role of orexin-containing neurons in arousal states, critical for higher order functioning. From a clinical perspective, genetic polymorphisms in hypocretin/orexin and orexin receptors are implicated in a number of psychiatric disorders. In addition, advanced clinical trials are currently underway for orexin receptor antagonists in the treatment of insomnia and sleep disorders. We aim to capture a broad audience of basic scientists and clinicians. 410 0$aCurrent Topics in Behavioral Neurosciences,$x1866-3370 ;$v33 606 $aNeurosciences 606 $aPharmacology 606 $aPsychopharmacology 606 $aBehavioral sciences 606 $aNeurology  606 $aPain medicine 606 $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 606 $aPsychopharmacology$3https://scigraph.springernature.com/ontologies/product-market-codes/H53010 606 $aBehavioral Sciences$3https://scigraph.springernature.com/ontologies/product-market-codes/L13009 606 $aNeurology$3https://scigraph.springernature.com/ontologies/product-market-codes/H36001 606 $aPain Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H47003 615 0$aNeurosciences. 615 0$aPharmacology. 615 0$aPsychopharmacology. 615 0$aBehavioral sciences. 615 0$aNeurology . 615 0$aPain medicine. 615 14$aNeurosciences. 615 24$aPharmacology/Toxicology. 615 24$aPsychopharmacology. 615 24$aBehavioral Sciences. 615 24$aNeurology. 615 24$aPain Medicine. 676 $a612.405 702 $aLawrence$b Andrew J$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $ade Lecea$b Luis$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910253921503321 996 $aBehavioral Neuroscience of Orexin$91993965 997 $aUNINA